Recent Press Releases

Pneumococcal disease: More cases but fewer deaths

Pneumococcal disease: More cases but fewer deaths Public release date: 7-May-2012 The vaccine given to children to immunise against serious pneumococcal disease does not offer full protection,...

NovaDigm Therapeutics Presents Positive Safety and Immunogenicity Data in a Second Phase 1 Study for NDV-3 Vaccine

NovaDigm Therapeutics Presents Positive Safety and Immunogenicity Data in a Second Phase 1 Study for NDV-3 Vaccine --NDV-3 is the First "Cross-Kingdom" Vaccine Being Developed for Candida and Staph...

Study confirms early elevated HIV infection risk in some Step study participants who received vaccine; risk decreased over time

Study confirms early elevated HIV infection risk in some Step study participants who received vaccine; risk decreased over time After about 18 months, risk level decreased to that of volunteers who...

H1N1 discovery paves way for universal flu vaccine: UBC research

H1N1 discovery paves way for universal flu vaccine: UBC research University of British Columbia researchers have found a potential way to develop universal flu vaccines and eliminate the need for...

Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy

Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy LANCASTER, Pa. and ROCKVILLE, Md., May 3, 2012 /PRNewswire via...

New vaccine shows promise to protect against common cause of meningitis

New vaccine shows promise to protect against common cause of meningitis Monday, 7 May 2012 Researchers are an important step closer to finding a vaccine that protects against a wide range of strains...

Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine

Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine - Pediatric Data Supplements Prior Phase II and Phase III Studies in Adults - SWIFTWATER, Pa., May 1, 2012...

Allergy Therapeutics - Board Appointment

Allergy Therapeutics - Board Appointment 2 May 2012 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Appointment of a Non-Executive Director Allergy...

Galena Biopharma Expands Folate Binding Protein Vaccine Intellectual Property With Notice of Allowance for U.S. Patent

Galena Biopharma Expands Folate Binding Protein Vaccine Intellectual Property With Notice of Allowance for U.S. Patent • Composition of Matter patent covers FBP peptide variants for individual...

Profectus BioSciences Receives NIAID Grant to Develop a Vesicular Stomatitis Virus-vectored Vaccine for Ebola and Marburg Viruses

Profectus BioSciences Receives NIAID Grant to Develop a Vesicular Stomatitis Virus-vectored Vaccine for Ebola and Marburg Viruses Funding to Support Profectus and Galveston National Laboratory...

Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine

Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine Pediatric Data Supplements Prior Phase II and Phase III Studies in Adults - SWIFTWATER, Pa., May 1,...

Mimopath-based influenza vaccine protects against both homologous and heterologous challenge

Mimopath-based influenza vaccine protects against both homologous and heterologous challenge Groningen, the Netherlands, May 3, 2012 / B3C newswire / - Dutch biotechnology company Mucosis B.V....

Hemispherx Biopharma Announces Test of Ampligen® with FluMist

Hemispherx Biopharma Announces Test of Ampligen® with FluMist …. First Intranasal Administration in Humans Philadelphia, PA, Monday, April 30, 2012: Hemispherx Biopharma, Inc. (NYSE...

Researchers Are Creating Designer Lymph Nodes Based on Moffitt Cancer Center s Total Cancer Care Initiative

Researchers Are Creating Designer Lymph Nodes Based on Moffitt Cancer Center s Total Cancer Care Initiative Gene-modified cells to produce functioning lymph nodes to augment and rebuild immune...

NOVAVAX Launches Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate

NOVAVAX Launches Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate ROCKVILLE, Md., May 2, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it has begun enrollment...

Japan Chooses Sanofi Pasteur for First Enhanced Inactivated Polio Vaccine

Japan Chooses Sanofi Pasteur for First Enhanced Inactivated Polio Vaccine April 27, 2012 - Approval of IMOVAX® POLIO by Japanese health authorities, a major milestone towards a polio-free world -...

GlaxoSmithKline receives European authorisation for Nimenrix™ (Meningococcal group A, C, W-135 and Y conjugate vaccine)

GlaxoSmithKline receives European authorisation for Nimenrix™ (Meningococcal group A, C, W-135 and Y conjugate vaccine) Issued: Friday 27 April 2012, London UK GlaxoSmithKline plc (GSK)...

Innovative ideas flourish in pilot program to promote vaccination in developing nations

Public release date: 22-Apr-2012 Innovative ideas flourish in pilot program to promote vaccination in developing nations Canadian center awards micro-grants to support grass-root efforts in Pakistan,...

Biovest and U.S. Army Enter into Collaborative Agreement to Develop Novel Bioreactor Systems as Platform Technology for Production of Anti-Viral Vaccines and Drugs

Biovest and U.S. Army Enter into Collaborative Agreement to Develop Novel Bioreactor Systems as Platform Technology for Production of Anti-Viral Vaccines and Drugs TAMPA, Fla. & MINNEAPOLIS, Apr...

Medicago Successfully Completes Research Collaboration Agreement with Top 10 Global Pharmaceutical Company for the Development of a Non-influenza VLP Vaccine Candidate

Medicago Successfully Completes Research Collaboration Agreement with Top 10 Global Pharmaceutical Company for the Development of a Non-influenza VLP Vaccine Candidate QUEBEC CITY, April 17, 2012...